JP2006522076A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522076A5
JP2006522076A5 JP2006505764A JP2006505764A JP2006522076A5 JP 2006522076 A5 JP2006522076 A5 JP 2006522076A5 JP 2006505764 A JP2006505764 A JP 2006505764A JP 2006505764 A JP2006505764 A JP 2006505764A JP 2006522076 A5 JP2006522076 A5 JP 2006522076A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
alkyl
alkyl group
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006505764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006522076A (ja
JP4711948B2 (ja
Filing date
Publication date
Priority claimed from FR0303924A external-priority patent/FR2852957B1/fr
Application filed filed Critical
Publication of JP2006522076A publication Critical patent/JP2006522076A/ja
Publication of JP2006522076A5 publication Critical patent/JP2006522076A5/ja
Application granted granted Critical
Publication of JP4711948B2 publication Critical patent/JP4711948B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006505764A 2003-03-31 2004-03-29 新規イミダゾピリジン誘導体及びその医薬としての使用 Expired - Fee Related JP4711948B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0303924A FR2852957B1 (fr) 2003-03-31 2003-03-31 Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
FR03/03924 2003-03-31
PCT/FR2004/000785 WO2004089951A1 (fr) 2003-03-31 2004-03-29 Derives d’imidazo-pyridine ayant une affinite sur des recepteurs de la melanocortine

Publications (3)

Publication Number Publication Date
JP2006522076A JP2006522076A (ja) 2006-09-28
JP2006522076A5 true JP2006522076A5 (enExample) 2011-03-10
JP4711948B2 JP4711948B2 (ja) 2011-06-29

Family

ID=32947292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505764A Expired - Fee Related JP4711948B2 (ja) 2003-03-31 2004-03-29 新規イミダゾピリジン誘導体及びその医薬としての使用

Country Status (17)

Country Link
US (1) US7495009B2 (enExample)
EP (1) EP1615925B1 (enExample)
JP (1) JP4711948B2 (enExample)
KR (1) KR101102742B1 (enExample)
CN (1) CN100455581C (enExample)
AT (1) ATE432280T1 (enExample)
AU (1) AU2004228416B9 (enExample)
BR (1) BRPI0408817A (enExample)
CA (1) CA2520855C (enExample)
DE (1) DE602004021247D1 (enExample)
ES (1) ES2327929T3 (enExample)
FR (1) FR2852957B1 (enExample)
IL (1) IL170834A (enExample)
MX (1) MXPA05010278A (enExample)
NZ (1) NZ542763A (enExample)
RU (1) RU2358974C2 (enExample)
WO (1) WO2004089951A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862971B1 (fr) * 2003-11-28 2006-03-24 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
TW200911803A (en) * 2007-07-16 2009-03-16 Organon Nv 6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
EP2072050A1 (en) 2007-12-21 2009-06-24 Santhera Pharmaceuticals (Schweiz) AG Compounds with anti-emetic effect
EP2072516A1 (en) * 2007-12-21 2009-06-24 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as Melancortin-4 receptor antagonists
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
EP2168965A1 (en) * 2008-09-25 2010-03-31 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists
US8410284B2 (en) 2008-10-22 2013-04-02 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
UY32470A (es) 2009-03-05 2010-10-29 Boehringer Ingelheim Int Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
CA2807093A1 (en) 2010-08-05 2012-02-09 Amgen Inc. Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
US8586604B2 (en) 2010-08-20 2013-11-19 Boehringer Ingelheim International Gmbh Inhibitors of the microsomal prostaglandin E2 synthase-1
US8759537B2 (en) 2010-08-20 2014-06-24 Boehringer Ingelheim International Gmbh 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
US8466186B2 (en) 2010-12-10 2013-06-18 Boehringer Ingelheim International Gmbh Compounds
US8674113B2 (en) 2010-12-10 2014-03-18 Boehringer Ingelheim International Gmbh Compounds
US8486968B2 (en) 2010-12-10 2013-07-16 Boehringer Ingelheim International Gmbh Compounds
WO2012100342A1 (en) 2011-01-27 2012-08-02 Université de Montréal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
PH12013501686A1 (en) 2011-02-25 2017-10-25 Merck Sharp & Dohme Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
ES2732077T3 (es) 2011-12-29 2019-11-20 Rhythm Pharmaceuticals Inc Método para tratar trastornos asociados con el receptor de melanocortina-4 en portadores heterocigotos
US9296745B2 (en) * 2012-04-06 2016-03-29 Pfizer Inc. Diacylglycerol acyltransferase 2 inhibitors
CA2880901A1 (en) 2012-08-02 2014-02-06 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
RU2015140066A (ru) 2013-02-22 2017-03-30 Мерк Шарп И Доум Корп. Противодиабетические бициклические соединения
WO2014139388A1 (en) 2013-03-14 2014-09-18 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
CN118240012A (zh) 2013-03-15 2024-06-25 节奏制药公司 肽组合物
EP2970389B1 (en) 2013-03-15 2020-08-19 Rhythm Pharmaceuticals, Inc. Pharmaceutical compositions
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US9067914B1 (en) 2013-12-10 2015-06-30 Genzyme Corporation Tropomyosin-related kinase (TRK) inhibitors
CN110950862B (zh) 2014-12-18 2024-01-05 建新公司 原肌球蛋白相关激酶(trk)抑制剂的药物制剂
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
WO2018118670A1 (en) 2016-12-20 2018-06-28 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds
US20200399268A1 (en) * 2018-02-16 2020-12-24 UCB Biopharma SRL Pharmaceutical 6,5 Heterobicyclic Ring Derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416433A1 (de) * 1994-05-10 1995-11-16 Hoechst Ag Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten
DE19503160A1 (de) * 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden
UA62972C2 (en) * 1997-07-03 2004-01-15 Application of imidazopyrimidins and imidazopyridins for the treatment of neural disorders
CA2377369A1 (en) * 1999-06-04 2000-12-14 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists
AU6621600A (en) * 1999-08-04 2001-03-05 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
AU2001236919A1 (en) 2000-02-09 2001-08-20 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses
JP2003534377A (ja) * 2000-05-30 2003-11-18 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作働薬
ES2331250T3 (es) * 2000-12-15 2009-12-28 Vertex Pharmaceuticals Incorporated Inhibidores de la girasa bacteriana y usos de los mismos.
WO2003059289A2 (en) * 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues

Similar Documents

Publication Publication Date Title
JP2006522076A5 (enExample)
JP2006521359A5 (enExample)
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
JP2005523310A5 (enExample)
PT1414441E (pt) Inibidores da polimerase do vírus da hepatite c com estrutura heterobicíclica
EP1953154A4 (en) CINNAMIDE COMPOUNDS OF MORPHOLINE TYPE
JP2005514398A5 (enExample)
ATE556058T1 (de) 1-(2h)-isochinolonderivat
JP2005289914A5 (enExample)
JP2007527909A5 (enExample)
JP2007519618A5 (enExample)
DE602004031722D1 (de) Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
CY1111271T1 (el) Παραγωγο τριαζολονης
JP2013515037A5 (enExample)
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
JP2008539193A5 (enExample)
EA200701035A1 (ru) Замещенные n-сульфониламинобензил-2-феноксиацетамидные соединения
IL177998A0 (en) Process for the preparation of aminopyrimidines
WO2007061966A3 (en) Amidinylphenyl compounds and their use as fungicides
WO2007147770A3 (en) Substituted phenyl methanone derivatives
EA201070758A1 (ru) Производные азетидинов, их получение и применение в терапии
AR044657A1 (es) Derivados de imidazol sustituidos con heteroarilo, metodos para su preparacion y su empleo en la fabricacion de medicamentos.
TW200503699A (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
ATE525386T1 (de) 3'-ethynylcytidinderivat